M. Elisaf's Profile

Role	Title	Level	Year	L/R
🐢	Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. E. Rizos, E. Ntzani, E. Bika, M. Kostapanos, M. Elisaf	9	2012	9 🐢
🐬	The impact of serum uric acid on cardiovascular outcomes in the LIFE study. S. Daskalopoulou, V. Athyros, M. Elisaf, D. Mikhailidis	8	2004	8 🐬
🐢	A review of drug-induced hyponatremia. G. Liamis, H. Milionis, M. Elisaf	8	2008	8 🐢
🐬	Effects of Thyroid Dysfunction on Lipid Profile C. Rizos, M. Elisaf, E. Liberopoulos	8	2011	8 🐬
🐢	The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study 7 auth. V. Athyros, D. Mikhailidis, A. Papageorgiou, A. Symeonidis, A. Pehlivanidis, V. Bouloukos, ... M. Elisaf	8	2004	8 🐢
🐢	Orlistat-Associated Adverse Effects and Drug Interactions T. Filippatos, C. Derdemezis, I. Gazi, E. Nakou, D. Mikhailidis, M. Elisaf	8	2008	8 🐢
🐬	Platelets as Predictors of Vascular Risk: Is There a Practical Index of Platelet Activity? S. Tsiara, M. Elisaf, I. Jagroop, D. Mikhailidis	8	2003	8 🐬
🐢	Diabetes mellitus and electrolyte disorders. G. Liamis, E. Liberopoulos, F. Barkas, M. Elisaf	8	2014	8 🐢
🐜	Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. 11 auth. V. Panoulas, K. Douglas, H. Milionis, Antonios, Stavropoulos-Kalinoglou, P. Nightingale, ... Marina D. Kita, Andreas L. Tselios, G. Metsios, M. Elisaf, G. Kitas	8	2007	8 🐜
🐢	Adverse Effects of GLP-1 Receptor Agonists. T. Filippatos, T. Panagiotopoulou, M. Elisaf	8	2014	8 🐢
🐬	Adult cardiovascular risk factors in premature babies D. Kiortsis, M. Elisaf, A. Evangelou	8	2000	8 🐬
🐢	Elevated serum uric acid levels in metabolic syndrome: an active component or an innocent bystander? S. Tsouli, E. Liberopoulos, D. Mikhailidis, V. Athyros, M. Elisaf	8	2006	8 🐢